Patents Assigned to Conimar AB
  • Publication number: 20110046742
    Abstract: A fibre-based surgical implant stabilized against fraying, includes a thermally crimped flat-knitted fabric of a biocompatible, optionally biodegradable, polymer material having a glass transition temperature or other thermally induced secondary conformational mobility threshold in the temperature range of from 20° C. to +170° C. Also disclosed is a corresponding fabric and methods of producing the implant and the fabric.
    Type: Application
    Filed: January 16, 2009
    Publication date: February 24, 2011
    Applicant: CONIMAR AB
    Inventors: Anders Persson, Eugenio Ferrario
  • Publication number: 20070281005
    Abstract: A method of treating or preventing Obstructive Sleep Apnea (OSA) comprises the administration of a pharmacologically effective amount of zonisamide to a patient in need thereof, with the proviso that OSA caused by external mechanical obstruction of the airways, such as by mucus, is excluded. Also disclosed is the use of zonisamide for the manufacture of a medicament useful in the treatment; a protective patch comprising zonisamide and a pharmaceutically acceptable carrier for transdermal or transmucosal administration to a person suffering from OSA; and the use of zonisamide for the manufacture of a diagnostic device, kit or composition for the diagnosis of sleep disordered breathing.
    Type: Application
    Filed: February 15, 2005
    Publication date: December 6, 2007
    Applicant: Conimar AB
    Inventors: Ludger Grote, Kaj Stenlof, Jan Hedner
  • Publication number: 20020177171
    Abstract: A method for identifying the susceptibility of a person to dental caries comprises the assay of one or several of: an agent having high binding capacity to Streptococcus mutans but low binding capacity to Actinomyces naeslundii, an agent having high binding capacity to S. mutans-binding agglutinin, an agent having high binding capacity to A. naeslundii. The agent having high binding capacity to Streptococcus mutans but low binding capacity to A. naeslundii comprises an allelic Db type of salivary acidic proline-rich molecules (acidic PRPs), a biologically active fragment or a genetic precursor thereof. A corresponding reagent is also identified. Also disclosed are a method and an agent for the prevention of caries, as well as labelled S. mutans and A. naeslundii and their use.
    Type: Application
    Filed: July 29, 2002
    Publication date: November 28, 2002
    Applicant: Conimar AB
    Inventor: Nicklas Stromberg